Alphabetical Index | Geographical Index | Specialty Index

---

LaVoieHealthScience

20 Park Plaza, Suite 312, Boston, MA 02116

617/374-8800

[email protected]

lavoiehealthscience.com
LaVoieHealthScience connects your medical and scientific breakthroughs with the world. We bridge health and science brands from inception to commercialization with time-tested communications programs.

Employees: 12. Founded: 2001.

Agency Statement:

LaVoieHealthScience partners with emerging, government, and commercial organizations to protect reputation and to advance their missions. We are a team of specialized leaders who possess a love for the ‘why’. The complexity of the business of science, medicine, and technology requires leaders to create a unique voice in a highly regulated industry. We guide leaders using our 20+ years of history with modern perspectives and time-tested results.

Donna L. LaVoie, President & CEO; Lisa DeScenza, Sr. VP & Head of New Business; Nina Gill, Sr. VP, Public Relations & Communications; Ella Deych, Sr. VP, Finance & COO

LaVoieHealthScience in the news with O'Dwyer's:

•	On the Move: LaVoieHealthScience Goes with Gill Thu., Apr. 10, 2025 ... Nina Gill LaVoieHealthScience  hires Nina Gill as SVP, PR & communications. Gill was most recently SVP at 10Fold Communications....

•	LaVoieHealthScience Lands $4M GSA Pact Thu., Mar. 27, 2025 ... LaVoieHealthScience is awarded the first five-year option period of a twenty-year General Services Administration Multiple...

•

News of Firms: Zapwater Launches Bilingual Unit to Serve Latin America Wed., Oct. 18, 2023 ...agencies across its Americas region: Carve Communications (Miami), Chirp PR (Atlanta), Curious Public (Toronto), Ditto PR (New York), LaVoieHealthScience  (Boston) and The TASC Group (New York). The network has also formed a Partner Value Committee,...

•	News of Firms: LaVoieHealthScience Launches Emerging Health Convergence Practice. Fri., Apr. 14, 2023 ... LaVoieHealthScience launches its Emerging Health Convergence Practice, which focuses on clients in drug development and...

 Printer Friendly